Smith & Nephew (LON:SN) Shares Cross Above 200 Day Moving Average - Time to Sell?

Key Points

• Smith & Nephew shares have crossed above their 200-day moving average, reaching a trading price of GBX 1,435 ($19.42), with a significant volume of 2.31 million shares traded.
• Analysts have shown confidence in Smith & Nephew, with price targets raised by firms like JPMorgan and Deutsche Bank, and a consensus rating of "Hold".
• Insider activity includes multiple purchases, amounting to a total of 4,811 shares acquired by corporate insiders over the past 90 days.

Shares of Smith & Nephew plc (LON:SN - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,136.08 ($15.38) and traded as high as GBX 1,435 ($19.42). Smith & Nephew shares last traded at GBX 1,435 ($19.42), with a volume of 2,313,437 shares traded.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on SN. Berenberg Bank increased their price objective on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a "hold" rating in a research report on Thursday, August 7th. JPMorgan Chase & Co. raised their price target on shares of Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an "overweight" rating in a research report on Wednesday, August 6th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a "hold" rating in a research report on Wednesday, August 6th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Smith & Nephew presently has a consensus rating of "Hold" and a consensus price target of GBX 1,379.33.

Smith & Nephew Stock Performance

The company's 50-day simple moving average is GBX 1,258.72 and its 200 day simple moving average is GBX 1,136.08. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock has a market cap of £15.73 billion, a P/E ratio of 51.67, a PEG ratio of 0.46 and a beta of 0.62.

Insider Activity at Smith & Nephew

In related news, insider Katarzyna Mazur Hofsaess purchased 541 shares of the firm's stock in a transaction dated Friday, August 22nd. The stock was bought at an average price of GBX 1,385 per share, for a total transaction of £7,492.85. Also, insider Jeremy (Jez) Maiden purchased 353 shares of the firm's stock in a transaction dated Friday, August 22nd. The shares were bought at an average price of GBX 1,378 per share, with a total value of £4,864.34. Insiders have bought a total of 4,811 shares of company stock worth $12,947,701 over the last 90 days. Corporate insiders own 0.19% of the company's stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.